Elisabet Josefsson Selected Research

Elisabet Josefsson Research Topics

Disease

12	Infectious Arthritis (Septic Arthritis) 10/2015 - 02/2004
11	Infections 01/2017 - 02/2004
9	Arthritis (Polyarthritis) 01/2015 - 11/2002
5	Inflammation (Inflammations) 01/2015 - 03/2005
5	Sepsis (Septicemia) 01/2015 - 05/2005
4	Staphylococcal Infections 08/2011 - 02/2004
3	Weight Loss (Weight Reduction) 10/2015 - 03/2005
3	Abscess 10/2015 - 09/2013
2	Disease Progression 01/2015 - 11/2011
2	Rheumatoid Arthritis 11/2011 - 01/2009
1	Persistent Infection 01/2016
1	Synovitis 01/2015
1	Necrosis 12/2014
1	Experimental Arthritis 11/2011
1	Shock 08/2011
1	Edema (Dropsy) 03/2006
1	Hypersensitivity (Allergy) 03/2006
1	Gout 03/2006

Drug/Important Bio-Agent (IBA)

8	Virulence Factors (Pathogenicity Factors)IBA 05/2008 - 11/2002
5	Membrane Proteins (Integral Membrane Proteins)IBA 12/2014 - 03/2005
5	factor AIBA 05/2008 - 02/2004
4	Fibrinogen (Factor I)FDA Link 05/2008 - 02/2004
3	Staphylococcus aureus auR protein (staphylokinase)IBA 01/2017 - 10/2010
3	Proteins (Proteins, Gene)FDA Link 08/2011 - 03/2005
3	Carrier Proteins (Binding Protein)IBA 03/2005 - 02/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2015 - 08/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 08/2011
2	PlasminogenIBA 09/2013 - 10/2010
2	Interleukin-6 (Interleukin 6)IBA 05/2008 - 03/2005
2	EnzymesIBA 02/2008 - 11/2007
2	Staphylococcal Protein A (Protein A)IBA 12/2005 - 11/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Galectin 3 (LGALS3)IBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 10/2015
1	Abatacept (Orencia)FDA Link 10/2015
1	Toll-Like Receptor 2IBA 01/2015
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2015
1	Receptor for Advanced Glycation End ProductsIBA 01/2015
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2015
1	Cloxacillin (Tegopen)FDA Link 01/2015
1	Bacterial DNAIBA 01/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2015
1	FibrinIBA 11/2011
1	Hemostatics (Antihemorrhagics)IBA 08/2011
1	Enterotoxins (Enterotoxin)IBA 08/2011
1	Tumor Necrosis Factor InhibitorsIBA 08/2011
1	Opsonin Proteins (Opsonins)IBA 03/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2009
1	MineralsIBA 01/2009
1	salicylhydroxamic acid (SHAM)IBA 01/2009
1	Collagen Type II (Type II Collagen)IBA 01/2009
1	CollagenIBA 01/2009
1	Estrogens (Estrogen)FDA Link 01/2009
1	Nonesterified Fatty Acids (NEFA)IBA 01/2009
1	sortase AIBA 02/2008
1	Messenger RNA (mRNA)IBA 02/2008
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 11/2007
1	Nucleic AcidsIBA 03/2006
1	RNA (Ribonucleic Acid)IBA 03/2006
1	SuspensionsIBA 03/2006
1	Biological ProductsIBA 03/2006
1	Uric Acid (Urate)IBA 03/2006
1	AntigensIBA 12/2005
1	SuperantigensIBA 12/2005
1	AntibodiesIBA 12/2005
1	Immunoglobulin G (IgG)IBA 12/2005
1	Tissue Adhesives (Tissue Adhesive)IBA 03/2005
1	Fibronectins (Fibronectin)IBA 03/2005
1	Ancrod (Arvin)IBA 02/2004

Therapy/Procedure

5	Therapeutics 01/2016 - 08/2011
1	Catheters 01/2016
1	Intra-Articular Injections 01/2015
1	Subcutaneous Injections 12/2014
1	Thrombolytic Therapy 11/2011